AJP - Heart AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (March 11, 2004). doi:10.1152/ajpheart.00699.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/1/H419    most recent
00699.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Back, M.
Right arrow Articles by Sakata, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Back, M.
Right arrow Articles by Sakata, K.
Submitted on July 23, 2003
Accepted on March 4, 2004

Leukotriene B4 is an indirectly acting vasoconstrictor in guinea pig aorta via an inducible type of BLT receptor

Magnus Back1*, Hong Qui2, Jesper Z. Haeggstrom2, and Kiyoto Sakata1

1 Division of Physiology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
2 Division of Physiological Chemistry 2, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

* To whom correspondence should be addressed. E-mail: Magnus.Back{at}cmm.ki.se.

Leukotriene B4 (LTB4) is a potent leukocyte chemoattractant, recently implicated in the pathogenesis of atherosclerosis. The aim of this study was to assess the effects of LTB4 on isolated aortic preparations. Rings of guinea pig aorta were challenged with LTB4 for recording of mechanical responses and measurements of mediator release, and LTB4 receptor (BLT1) receptor expression was assessed by RT-PCR. Single concentrations of LTB4 induced concentration-dependent contractions that were inhibited by treatment with antihistamines, indomethacin or the TP receptor antagonist BAYu3405, as well as by denudation of endothelium. In addition, LTB4 increased the release of histamine and thromboxane in the bath. The contractions induced by LTB4 were inhibited by either the unselective BLT receptor antagonist ONO-4057 or the selective BLT1 receptor antagonist U-75509. Pre-treatment with alltrans retinoic acid enhanced the contractions and the release of histamine induced by LTB4, without affecting either the contractions induced by histamine, or the histamine release evoked by calcium ionophore A23187. Analysis by RT-PCR indicated the expression of a BLT1 receptor in the guinea pig aorta, and that BLT1 receptor mRNA was up-regulated after treatment with retinoic acid. These results suggest that LTB4 contracts the guinea pig aorta via an indirect mechanism involving the release of histamine and thromboxane and that this BLT1 receptor mediated response can be upregulated by all-trans retinoic acid.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
E. Sanchez-Galan, A. Gomez-Hernandez, C. Vidal, J. L. Martin-Ventura, L. M. Blanco-Colio, B. Munoz-Garcia, L. Ortega, J. Egido, and J. Tunon
Leukotriene B4 enhances the activity of nuclear factor-{kappa}B pathway through BLT1 and BLT2 receptors in atherosclerosis
Cardiovasc Res, January 1, 2009; 81(1): 216 - 225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.